Skip to content

A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy

fMRI of Active DBS Stimulation in Epilepsy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04753983
Enrollment
0
Registered
2021-02-15
Start date
2022-09-30
Completion date
2024-05-31
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Epilepsy

Keywords

Deep Brain Stimulation

Brief summary

The purpose of this study is to use functional imaging to study the mechanisms of the anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).

Detailed description

Researchers are testing how changing the settings on deep brain stimulation device (DBS) can help reduce the number and severity of seizures. Functional imaging will be used to study the mechanisms of ANT DBS to optimize the device settings to improve the degree of seizure reduction.

Interventions

DIAGNOSTIC_TESTFunctional magnetic resonance imaging (fMRI)

Diagnostic imaging measuring the metabolic changes that occur within the brain used for measuring and mapping brain activity

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients who have previously undergone anterior thalamic nucleus deep brain stimulation (DBS) for refractory epilepsy.

Exclusion criteria

\- Contraindication to MRI; prior brain resective surgery or large area of brain tissue loss (e.g., large area infarction).

Design outcomes

Primary

MeasureTime frameDescription
Document brain activation networks with ANT stimulationResults would be available immediately following processing of the imaging data after each scanUse resting state fMRI to map brain network activation with high and low frequency of ANT stimulation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026